Cortical thickness changes in patients with Parkinson's disease and impulse control disorders

Parkinsonism and Related Disorders

Volumn 24, Issue , 2016, Pages 119-125

  Tessitore, Alessandro ^a   Santangelo, Gabriella ^a,b   De Micco, Rosa ^a   Vitale, Carmine ^b,c   Giordano, Alfonso ^a,b   Raimo, Simona ^a   Corbo, Daniele ^d   Amboni, Marianna ^c   Barone, Paolo ^e   Tedeschi, Gioacchino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Istituto di Diagnosi e Cura Hermitage Capodimonte   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cortical thickness; Impulse control disorders; Parkinson's disease; Reward system

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ANTIPARKINSON AGENT;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR DISORDER ASSESSMENT; BRAIN ATROPHY; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; IMPULSE CONTROL DISORDER; LIMBIC CORTEX; MALE; MINNESOTA IMPULSIVE DISORDERS INTERVIEW; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; ORBITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; VOXEL BASED MORPHOMETRY; BRAIN CORTEX; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; IMAGE PROCESSING; MIDDLE AGED; NEUROLOGIC EXAMINATION; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL RATING SCALE; STATISTICS; X-RAY COMPUTED TOMOGRAPHY;

AGED; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84958854343     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.10.013     Document Type: Article

References (30)

1. Weintraub D., Nirenberg M.J. Impulse control and related disorders in Parkinson's disease. Neurodegener. Dis. 2013, 11:63-71.
2. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 2001, 11:1136-1143.
3. Santangelo G., Vitale C., Trojano L., Verde F., Grossi D., Barone P. Cognitive dysfunctions and pathological gambling in patients with Parkinsons's disease. Mov. Disord. 2009, 24:899-905.
4. Vitale C., Santangelo G., Trojano L., Verde F., Rocco M., Grossi D., et al. Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson's disease. Mov. Disord. 2011, 26:830-836.
5. Cilia R., Cho S.S., Van Eimeren T., Marotta G., Siri C., Ko J.H., et al. Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov. Disord. 2011, 26:225-233.
6. Voon V., Gao J., Brezing Z., Symmonds M., Ekanayake V., Fernandez H., et al. Dopamine agonist and risk: impulse control disorders in Parkinson's disease. Brain 2011, 134:1438-1446.
7. Cerasa A., Salsone M., Nigro S., Chiriaco C., Donzuso G., Bosco D., et al. Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling. Park. Relat. Disord. 2014, 20:1209-1214.
8. Biundo R., Weis L., Facchini S., Formento-Dojot P., Vallelunga A., Pilleri M., et al. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov. Disord. 2015, 30:688-695.
9. Narr K., Woods R., Thompson P.M., Szeszko P., Robinson D., Dimtcheva T., et al. Relationships between IQ and regional cortical grey matter thickness in healthy adults. Cereb. Cortex 2007, 17:2163-2171.
10. Fjell A.M., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., et al. High consistency of regional cortical thinning in aging across multiple samples. Cereb. Cortex 2009, 19:2001-2012.
11. Kaag A.M., Crunelle C.L., van Wingen G., Homberg J., van den Brink W., Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug Alcohol Depend. 2014, 144:210-217.
12. Li M., Tian J., Zhang R., Qiu Y., Wen X., Ma X., et al. Abnormal cortical thickness in heroin-dependent individuals. Neuroimage 2013, 88:295-307.
13. Yuan K., Cheng P., Dong T., Bi Y., Xing L., Yu D., et al. Cortical thickness abnormalities in late adolescence with online gaming addiction. PLoS One 2013, 8:e53055.
14. Shaw P., Sharp W., Sufre G., Wharton A., Greenstein D., Raznahan A., et al. Subcortical and cortical morphological anomalies as an endophenotype in obsessive-compulsive disorder. Mol. Psychiatry 2015, 20:224-231.
15. Cerasa A., Morelli M., Augimeri A., Salsone M., Novellino F., Gioia M.C., et al. Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. Park. Relat. Disord. 2013, 19:123-125.
16. Pereira J.B., Ibarretxe-Bilbao N., Marti M.J., Compta Y., Junqué C., Bargallo N., et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum. Brain Mapp. 2012, 33:2521-2534.
17. Zarei M., Ibarretxe-Bilbao N., Compta Y., Hough M., Junque C., Bargallo N., et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2013, 84:875-882.
18. Paulus M.P., Hozack N., Frank L., Brown G.G. Error rate and outcome predictability affect neural activation in prefrontal cortex and anterior cingulate during decision-making. Neuroimage 2002, 15:836-846.
19. Rolls E.T. The functions of the orbitofrontal cortex. Brain Cogn. 2004, 55:11-29.
20. Chamberlain S.R., Menzies L., Hampshire A., Suckling J., Fineberg N.A., del Campo N., et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321:421-422.
21. Morecraft R., Stilwell-Morecraft K., Cipolloni P., Ge J., McNeal D.W., Pandya D.N. Cytoarchitecture and cortical connections of the anterior cingulate and adjacent somatomotor fields in the rhesus monkey. Brain Res. Bull. 2012, 87:457-497.
22. Sullivan S.O.', Wu K., Politis M., Lawrence A.D., Evans A.H., Bose S.K., et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011, 134:969-978.
23. Money K.M., Stenwood G.D. Developmental origins of brain disorders: roles for dopamine. Front. Cell. Neurosci. 2013, 7:260.
24. Tamnes C.K., Ostby Y., Fjell A.M., Westlye L.T., Due-Tønnessen P., Walhovd K.B. Brain maturation in adolescence and young adulthood: regional age-related changes in cortical thickness and white matter volume and microstructure. Cereb. Cortex 2010, 20:534-548.
25. Voon V., Fernagut P.O., Wickens J., Baunez C., Rodriguez M., Pavon N., et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 2009, 8:1140-1149.
26. Singh A., Kandimala G., Dewey R.B., O'Suilleabhain P. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. J. Clin. Neurosci. 2007, 14:1178-1181.
27. Biundo R., Formento-Dojot P., Facchini S., Vallelunga A., Ghezzo L., Foscolo L., et al. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormatilities. J. Neurol. Sci. 2011, 310:64-69.
28. Winkler A.M., Kochunov P., Blangero J., Almasy L., Zilles K., Fox P.T., et al. Cortical thickness or grey matter volume? the importance of selecting the phenotype for imaging genetics studies. Neuroimage 2010, 53:1135-1146.
29. Carriere N., Lopes R., Defebvre L., Delmaire C., Dujardin K. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology 2015, 84:2116-2123.
30. Weintraub D., Mamikonyan E., Papay K., Shea J.A., Xie S.X., Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale. Mov. Disord. 2012, 27:242-247.